Early/Expanded Access

Important Additional Information About Early/Expanded Access to Enzalutamide (MDV-3100)

I now have some additional information about the Early/Expanded Access Program for Enzalutamide (MDV-3100)for men with advanced prostate cancer. Jan Manarite, who is a member of the Early Access Committee has provided the following information: From the Early/Expanded Access Committee - Now available in 10 states (see list below in this post) with additional states [...]

By Malecare|2017-10-19T10:51:07-04:00May 31st, 2012|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Drugs & Treatments, Early/Expanded Access Programs, Enzalutamide (MDV-3100), General Information, MDV3100, Uncategorized|3 Comments

Previous 12